title: The effect of various inflammatory agents on the alternative metabolic pathways of arginine in mouse and rat macrophages.
abstract: OBJECTIVE
  The effects of various inflammatory stimuli on the alternative arginine metabolic pathways in mouse and rat peritoneal macrophages were investigated in vitro and compared.
  
  
  METHODS
  Mice and rats were injected i. p. with thioglycollate, carrageenan, casein, BCG and Newcastle Disease Virus (NDV) vaccines.
  
  
  METHODS
  Peritoneal macrophages were isolated from untreated and treated animals. The activities of nitric oxide synthase (NOS) II and arginase were measured and expressions were followed by Western blotting. The uptake of arginine and nitrite formation of macrophages were also measured.
  
  
  RESULTS
  Inflammatory stimuli increased the NO production and the expression and activity of both NOS II and arginase in mice in vitro. On the contrary, the same treatments changed the expression and activity of NOS II only, but not those of arginase in rats. The most marked effects on NO metabolism were produced by casein and NDV treatments.
  
  
  CONCLUSIONS
  The activity and expression of NOS II and arginase can be stimulated in peritoneal macrophages in vitro by injecting inflammatory agents into the peritoneal cavity. A markedly different response in arginine metabolism was observed in mouse and rat macrophages. Casein treatment was a potent inducer for both enzymes. NDV vaccines induced mainly NOS II, while thioglycollate induced arginase.
authors.affiliation: Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary. hrabak@puskin.sote.hu
authors.forename: A
authors.initials: A
authors.lastname: Hrabák
authors.forename: T
authors.initials: T
authors.lastname: Bajor
authors.forename: I
authors.initials: I
authors.lastname: Csuka
mesh_terms: D000818:Animals; D001119:Arginase / Q000378:metabolism; D001120:Arginine / Q000378:metabolism*; D001500:BCG Vaccine / Q000494:pharmacology; D002351:Carrageenan / Q000494:pharmacology; D002364:Caseins / Q000494:pharmacology; D007249:Inflammation; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D009522:Newcastle disease virus / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism; D010537:Peritoneum / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013864:Thioglycolates / Q000494:pharmacology; D014765:Viral Vaccines / Q000494:pharmacology
chemical_list: D001500:BCG Vaccine; D002364:Caseins; D013864:Thioglycolates; D014765:Viral Vaccines; D002351:Carrageenan; D001120:Arginine; D052247:Nitric Oxide Synthase Type II; D001119:Arginase